| Literature DB >> 31711103 |
Hilary Daniel1, Sue S Bornstein2.
Abstract
Recent discussions about the increasing prices of prescription drugs have focused on pharmacy benefit managers (PBMs), third-party intermediaries for various types of employers and government purchasers who negotiate drug prices in health plans and thus play a crucial role in determining the amount millions of Americans pay for medications. In this position paper, the American College of Physicians expands on its position paper from 2016 by offering additional recommendations to improve transparency in the PBM industry and highlighting the need for reliable, timely, and relevant information on prescription drug pricing for physicians and patients.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31711103 DOI: 10.7326/M19-0035
Source DB: PubMed Journal: Ann Intern Med ISSN: 0003-4819 Impact factor: 25.391